Navigation Links
Biomatrica Secures Strategic Investment from IQT
Date:2/23/2011

SAN DIEGO, Feb. 23, 2011 /PRNewswire/ -- Biomatrica, Inc., a leader in room temperature biostability technology, today announced a strategic partnership agreement with In-Q-Tel (IQT). IQT is the independent, strategic investment firm that identifies innovative technology solutions to support the mission of the U.S. Intelligence Community.

Biomatrica has developed SampleMatrix® technology which has pioneered recent innovations in ambient storage of biological samples from purified DNA, RNA, and proteins as well as in complex systems such as tissue, cell lines, biopsies and whole blood. The company's products serve a wide range of customers such as those in the forensics, biomedical research (academic, government and industry), molecular diagnostics and biobanking. Biomatrica was recently recognized as a Finalist for the Most Innovative New Product Award (MIP) in the Life Science and Diagnostics category as conducted by San Diego's CONNECT.

"Biomatrica's technology capability is an important addition to our strategic investment portfolio," said Syd Ulvick, Vice President, Physical and Biological Technologies Practice at IQT. "The company's technology advances offer great promise for applications in both the government and commercial sector."

"As the needs of research and medicine to manage biological samples grow, increasing energy and environmental cost associated with cold storage of biological samples, it is critical for biobanks, research institutions and biotechnology companies to identify alternative storage solutions," said Judy Muller-Cohn, Ph.D., CEO and co-founder of Biomatrica. "The SampleMatrix technology allows for safe, long term preservation of biological samples at room temperature. Sample recovery is simple and sample integrity is assured."

SampleMatrix® is based on extremophile biology in which organisms are able to survive long-term in a state of anhydrobiosis (life without water) and later be revived by rehydration. Extremophiles such as tardigrades, also known as water bears, and brine shrimp are able protect their DNA, RNA, proteins, membranes and cellular systems in a dried state for extended periods of time. Biomatrica's technology mimics the natural molecular mechanisms used by these organisms. The technology works by forming a thermo-stable barrier during the drying process to protect samples from degradation during storage at room temperature.

About Biomatrica®, Inc.

Biomatrica (www.biomatrica.com) is a San Diego-based biostability company that provides innovative technologies for stabilizing, processing, storing and shipping biological samples at room temperature. The core technology is designed for use in preserving complex biological samples and assays and is based on the principles of anhydrobiosis ("life without water"), a natural mechanism that allows multicellular organisms to survive extreme environments. Biomatrica's current products stabilize DNA, RNA, proteins, cells and assays with no sample degradation, allowing scientists and clinicians to have pristine samples and reduce their reliance on freezers and drastically reduce shipping costs. Biomatrica products are used in laboratories performing life science research, from pharmaceutical and biotechnology companies to academic research and forensics laboratories. Custom services to stabilize additional sample types are also available. Biomatrica also offers SampleWare® software, an easy-to-use, customizable laboratory management database that provides scientists with the means to store and organize their sample data, and directly supports samples stabilized by Biomatrica technology. For more information about the SampleMatrix technology and the Biomatrica products utilizing this technology platform (DNAstable®, DNAstable Blood, DNAgard Tissue and DNAgard Blood for DNA, RNAstable® and RNAconcentrator for RNA, and CloneStable® for bacterial DNA), visit: www.biomatrica.com.

About IQT

In-Q-Tel is the strategic, not-for-profit investment firm that works to identify, adapt, and deliver innovative technology solutions to support the missions of the U.S. Intelligence Community. Launched in 1999 as a private, independent organization, IQT's mission is to identify and partner with companies developing cutting-edge technologies that serve the national security interests of the United States. Working from an evolving strategic blueprint defining the Intelligence Community's critical technology needs, IQT engages with entrepreneurs, growth companies, researchers, and investors to deliver technologies that provide superior capabilities for the CIA and the larger Intelligence Community. To learn more about IQT, visit www.iqt.org.


'/>"/>
SOURCE Biomatrica, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Biomatrica Launches DNAgard® Blood and DNAstable Blood for Stabilization, Storage and Shipping of Whole Blood at Room Temperature
2. Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture
3. Digital Assent Secures $2 Million Series A Financing to Grow PatientPad Point-of-Care Network
4. TechniScan Secures $10 Million Equity Financing Facility
5. Poniard Pharmaceuticals Completes Voluntary Prepayment of Term Loans and Secures New Committed Equity Financing Facility
6. MedShape Solutions, Inc. Secures Investment From IQT to Support U.S. Intelligence Community
7. Audax Medical, Inc. Secures Exclusive Rights to Novel Osteobiologic Nanotechnology
8. Sutro Biopharma Secures $36.5 Million in Series C Financing
9. K-V Pharmaceutical Secures Financing Commitments Establishing Path Forward For Specialty Pharmaceutical Business
10. Unilife Secures U.S. Government Financial Backing for the Completion of New Global Headquarters and Manufacturing Facility in York, PA
11. Prolong Pharmaceuticals Secures $30 Million in Funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... 2017 Companion animal ... in pets such as canine, avian and feline. ... types such as Attenuated Live Vaccines, Conjugate Vaccines, ... and Recombinant Vaccines. Attenuated live vaccines are derived ... which have been weakend under laboratory conditions. Conjugate ...
(Date:4/19/2017)... , April 19, 2017  SARES•REGIS Group leased ... is developing at Conejo Spectrum Business Park in ... Atara Biotherapeutics, Inc. , a biopharmaceutical company ... life-threatening diseases that have been underserved by scientific ... therapies for cancer, autoimmune and infectious disease. ...
(Date:4/18/2017)... , April 18, 2017 Viverae ® , ... announce the integration of IBM ® Watson Campaign ... deliver targeted communications for a personalized experience. Through digital ... on their health in real time. The enhanced experience ... most to members, wherever they are in their journey ...
Breaking Medicine Technology:
(Date:4/25/2017)... (PRWEB) , ... April 25, ... ... based in Newport Beach, California, committed to raising awareness for Duchenne muscular ... results from its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial ...
(Date:4/25/2017)... ... April 25, 2017 , ... As President Trump challenges ... for how his administration could impact the employee benefits industry. James Slotnick, AVP, ... most likely to make it through Congress. His discussion will focus on the ...
(Date:4/25/2017)... ... April 25, 2017 , ... The doctors at Wall Centre Dental ... with dental fear and require sedation to receive dental care. The doctors offer three ... procedures, from hygienic cleanings to oral surgery, at their dental office in Vancouver. Wall ...
(Date:4/25/2017)... ... April 25, 2017 , ... Patients who would like ... in a fraction of the time as traditional braces – Wilckodontics®. Dr. Victoria ... now offers this revolutionary treatment with or without a referral. , Wilckodontics ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... in unveiling cutting-edge birth defects research related to Zika virus during pregnancy, as ... premier society for this important science. , The Teratology Society ...
Breaking Medicine News(10 mins):